# Efficacy & Safety of Autologous Dendritic Cell Vaccination in Glioblastoma Multiforme After Complete Surgical Resection

> **NCT01006044** · PHASE2 · COMPLETED · sponsor: **Clinica Universidad de Navarra, Universidad de Navarra** · enrollment: 26 (actual)

## Conditions studied

- Glioblastoma Multiforme

## Interventions

- **BIOLOGICAL:** autologous dendritic cells

## Key facts

- **NCT ID:** NCT01006044
- **Lead sponsor:** Clinica Universidad de Navarra, Universidad de Navarra
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-10
- **Primary completion:** 2014-08
- **Final completion:** 2014-08
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2014-09-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01006044

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01006044, "Efficacy & Safety of Autologous Dendritic Cell Vaccination in Glioblastoma Multiforme After Complete Surgical Resection". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01006044. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*